Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
type: MedicalStudy
description: A Phase II Study of Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced Transitional Cell Carcinoma
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2000-05
end date: 2006-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00173862
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: National Taiwan University Hospital
study subject: Transitional Cell Carcinoma
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Transitional Cell Carcinoma

AI Analytics
type: Organization